创新药ETF富国(159748)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
6,820,732.28 |
161,623.50 |
521,508.02 |
66,783.32 |
| 存出保证金 |
27,021.23 |
43,447.42 |
18,383.15 |
7,283.92 |
| 交易性金融资产 |
790,748,354.31 |
558,972,040.67 |
369,318,452.36 |
245,449,515.45 |
| 其中:股票投资 |
790,748,354.31 |
558,972,040.67 |
369,318,452.36 |
245,449,515.45 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
47,340,620.26 |
118,787.25 |
1,199,824.39 |
957,961.10 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
602,467.98 |
- |
208,266.58 |
- |
| 应收申购款 |
- |
- |
- |
- |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
850,694,355.22 |
562,226,460.16 |
372,836,309.14 |
247,824,829.79 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
54,281,245.62 |
116.82 |
1,778,749.86 |
1,511,072.71 |
| 应付赎回款 |
- |
- |
- |
- |
| 应付管理人报酬 |
265,634.02 |
248,688.64 |
153,642.05 |
109,788.58 |
| 应付托管费 |
53,126.82 |
49,737.74 |
30,728.40 |
21,957.69 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
243,838.43 |
197,618.84 |
368,591.96 |
305,475.46 |
| 负债合计 |
54,843,844.89 |
496,162.04 |
2,331,712.27 |
1,948,294.44 |
| 所有者权益 |
| 实收基金 |
1,101,692,128.00 |
753,692,128.00 |
547,692,128.00 |
459,692,128.00 |
| 未分配利润 |
-305,841,617.67 |
-191,961,829.88 |
-177,187,531.13 |
-213,815,592.65 |
| 所有者权益合计 |
795,850,510.33 |
561,730,298.12 |
370,504,596.87 |
245,876,535.35 |
| 负债及所有者权益总计 |
850,694,355.22 |
562,226,460.16 |
372,836,309.14 |
247,824,829.79 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年